William G. Wierda, MD, PhD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses treatment options for patients with CLL who harbor the 17p deletion.
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
Ещё видео!